LEN vs PSA · rev $34.19B vs rev $4.82B
LEN (LEN) versus PSA (PSA) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
PSA (PSA) common stock.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported PSA revenue for 2025-12-31 was $4.82B. Net income was $1.78B. Revenue was up 2.7% from 2024-12-31 to 2025-12-31. PSA currently screens at market cap $0.
LEN currently screens at market cap $0. PSA currently screens at market cap $0.
Not investment advice. Open the LEN and PSA stock pages for the full models.
Not investment advice.